QA: Checkpoint Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651407_2024_Checkpoint_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001651407, Checkpoint Therapeutics Inc

  xvar xval
0 AssetsCurrent 5,378,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 18,425,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,678,554
9 ResearchAndDevelopmentExpense 44,348,977
10 remainder_Expenses 0
11 remainder_Revenues 126,118
12 remainder_NetIncome -4,248,956
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,378,000
1 Liabilities 18,425,000
2 Expenses 53,027,531
3 Revenues 126,118
4 StockholdersEquity -13,047,000
5 NetIncome -57,150,369
6 ComprehensiveNetIncome -57,150,369
7 BaseVar 40,602,802
8 EconomicCapitalRatiobeforeLimitedLiability -7.19
9 EconomicCapitalRatio 0.0225

Edgar->Model Mapping

Feature Distribution

Change over Time